|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 21.50 SEK | +0.70% |
|
+13.64% | -4.87% |
| 23/06 | Citadel Back as Public Short Seller in Synact Pharma | FW |
| 19/06 | Edison Maintains Its Valuation for Synact Pharma After Trial Results | FW |
| Market Cap | 1.14B 118M 103M 94.87M 87.78M 167M 11.23B 169M 445M 5.51B 441M 432M 19.09B | P/E 2026 * |
-14.3x | P/E 2027 * | -28.1x |
|---|---|---|---|---|---|
| Enterprise Value | 1.12B 116M 101M 93.41M 86.43M 164M 11.05B 167M 439M 5.43B 435M 425M 18.8B | EV / Sales 2026 * |
8.06x | EV / Sales 2027 * | 54.9x |
| Free-Float |
70.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: SynAct Pharma AB
| 1 day | +0.70% | ||
| 1 week | +13.64% | ||
| Current month | +2.14% | ||
| 1 month | +55.80% | ||
| 3 months | +20.11% | ||
| 6 months | -5.49% | ||
| Current year | -4.87% |
| 1 week | 17.9 |  | 23.5 |
| 1 month | 7.05 | | 23.5 |
| Current year | 7.05 | | 24.4 |
| 1 year | 7.05 | | 25.3 |
| 3 years | 4.98 | | 124.6 |
| 5 years | 4.98 | | 146 |
| 10 years | 4.75 | | 146 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
CEO | Chief Executive Officer | 64 | 01/01/2014 |
Ann Kristin Led
DFI | Director of Finance/CFO | - | 01/03/2026 |
Kirsten Harting
CTO | Chief Tech/Sci/R&D Officer | - | 15/02/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Jeppe Øvlesen
BRD | Director/Board Member | 64 | 20/03/2024 |
Anders Kronborg
CHM | Chairman | 62 | 20/03/2024 |
Sten Scheibye
BRD | Director/Board Member | 74 | 20/03/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 10/03 | Buy | Chairman | 2,750 | 0.0052% | ||
| 09/03 | Quantass ApS
| Buy | Company | 7,900 | 0.0148% | |
| 09/03 | Buy | Executive/Senior Manager | 1,500 | 0.0028% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.70% | +13.64% | +0.70% | -70.99% | 118M | |
| -2.30% | -0.71% | +50.70% | +162.93% | 1,085B | |
| -0.36% | -0.26% | +64.03% | +62.16% | 624B | |
| -1.13% | -3.07% | +26.64% | +83.61% | 442B | |
| +0.30% | -1.17% | +27.98% | +26.90% | 332B | |
| -3.88% | -10.87% | +21.25% | +26.56% | 277B | |
| +0.13% | -2.50% | +25.71% | +45.40% | 282B | |
| +0.20% | -1.65% | -29.43% | -39.44% | 217B | |
| -0.22% | -0.82% | +21.00% | +61.72% | 196B | |
| -2.31% | +1.88% | +15.29% | +74.46% | 167B | |
| Average | -0.93% | -0.15% | +22.39% | +43.33% | 362.21B | |
| Weighted average by Cap. | -1.32% | -1.06% | +35.74% | +82.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 139M 14.36M 12.56M 11.59M 10.72M 20.35M 1.37B 20.69M 54.39M 673M 53.92M 52.75M 2.33B | 21.15M 2.19M 1.92M 1.77M 1.63M 3.1M 209M 3.15M 8.29M 103M 8.22M 8.04M 355M |
| Net income | 52.18M 5.4M 4.72M 4.36M 4.03M 7.65M 515M 7.78M 20.45M 253M 20.27M 19.84M 877M | -26.04M -2.7M -2.36M -2.17M -2.01M -3.82M -257M -3.88M -10.21M -126M -10.12M -9.9M -438M |
| Net Debt | -17.48M -1.81M -1.58M -1.46M -1.35M -2.56M -173M -2.61M -6.85M -84.81M -6.79M -6.65M -294M | 24.86M 2.57M 2.25M 2.08M 1.92M 3.65M 246M 3.71M 9.75M 121M 9.66M 9.45M 418M |
Employees
8
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/07/26 | SEK 21.50 | +0.70% | 416,379 |
| 09/07/26 | SEK 21.35 | +10.39% | 422,177 |
| 08/07/26 | SEK 19.34 | +0.21% | 345,402 |
| 07/07/26 | SEK 19.30 | +0.42% | 366,957 |
| 06/07/26 | SEK 19.22 | +1.59% | 211,207 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SYNACT Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
